Human Microbiome Market Global Research and Clinical Analysis 2021 to 2026 - AOBiome, Astarte Medical, Axial Biotherapeutics, DuPont

The “Global Human Microbiome Market” Research Report 2021-2026 is an in-depth study of the market, along with an analysis of its key segments. The relationship is built through extensive primary and secondary research. In-depth market data is generated through interviews and data collection from industry experts and professionals. The study is a detailed document on key aspects of the markets including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis.

The global human microbiome market is expected to register a CAGR of nearly 17% over the forecast period.

Click the link to get a free Sample Copy of the Report: (Flat 25%)

https://www.marketinsightsreports.com/reports/05202907389/human-microbiome-market-growth-trends-covid-19-impact-and-forecast-2021-2026/inquiry?Source=MS&Mode=28              

The research report is a compilation of key data with regards to the competitive landscape of this vertical and the multiple regions where the business has successfully established its position.

Top Companies in the Global Human Microbiome Market: AOBiome, Astarte Medical, Axial Biotherapeutics, DuPont, Enterome Bioscience, Evelo Biosciences, Finch Therapeutics, Ginkgo Bioworks, Nextbiotix, Osel Inc., Second Genome Inc., and Other.

Key Market Trends:

Therapeutic Applications is Expected to Hold the Highest Share over the Forecast Period:

Microbiome therapeutics has found a broad range of applications in the arena of Covid- 19, Inflammatory Bowel Disease (IBD), C. difficile infections, Crohn’s disease, and diabetes. Rising research activities undertaken by research institutes for finding more therapeutic applications of the human microbiome are expected to accentuate growth.

For instance, in 2020, the University of Zurich is also investigating the microbiota in COVID-19 patients for future preventive and therapeutic approaches (MICRO-COV). Positive results from these research studies will open up the growth avenues to the segment studied.

Furthermore, the rising efforts of pharmaceutical companies for the development of novel drugs is also a high impact rendering factor for growth. According to a report by Seventure Partners, a French VC investor, in 2018 alone, over 2400 clinical trials were registered as the testing therapies on microbiome science.

In July 2019, the Microbiome Therapeutics Innovation Group joined Siolta Therapeutics to its coalition of companies, leading the R&D of microbiome therapeutics and microbiome-based products. All the aforementioned factors is likely to boost the segmental growth over forecast period.

Regional Analysis:

North America Dominates the Market and Expected to do Same over the Forecast Period

North America currently dominates the market for the human microbiome due to the rising incidences of lifestyle-related diseases and autoimmune disorders in these regions. The presence of a strong drug pipeline can also be attributed to the highly lucrative growth. For instance, in 2020, Seres Therapeutics' stool-derived treatment for recurrent Clostridium difficile infection has cleared the phase-III of clinical trials.

Furthermore, in August 2019, the Stanford Microbiome Therapies Initiative (MITI), a joint initiative between Stanford ChEM-H and the Department of Bioengineering was launched to harness the communities of microbes inhabiting human bodies, known as the microbiome in developing new therapies for debilitating diseases.

As per an article in BioMed Central Journal, 2019, the National Institutes of Health (NIH) provides support to the microbiome project, with 21 out of 27 NIH institutes supporting and funding this area through extramural projects.

Also, in 2019, Government of Canada announced an investment of USD 18 million for microbiome research. This investment will support seven research teams from across the country that will study the microbiome to better understand its contribution to childhood asthma, cervical cancer, diabetes, youth inflammatory bowel disease, and maternal malnutrition. Thus, these research initiatives and rising government funding have established North America as one of the major markets in the human microbiome and helped this market to grow at a healthy rate.

Ask for TOC and Report Description:

https://www.marketinsightsreports.com/reports/05202907389/human-microbiome-market-growth-trends-covid-19-impact-and-forecast-2021-2026?Source=MS&Mode=28             

What are the market factors that are explained in the report?

-Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a Global and regional scale.

-Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

–Analytical Tools: The Global Human Microbiome Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.

The research includes historic data from 2015 to 2021 and forecasts until 2026 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Market Insights Reports
4893, Pepper drive, Harrisburg ,NC 28075,United States

Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com
irfan@marketinsightsreports.com

We also offer customization on reports based on specific client requirements:
1- Free country level analysis for any 5 countries of your choice.
2- Free competitive analysis of any 5 key market players.
3- Free 40 analyst hours to cover any other data points

This release was published on openPR.